Pharmaceutical Properties
Rituximab is also known as Rituxan (brand name). It is directed against CD20 antigen as it is a genetically engineered IgG1 monoclonal kappa antibody. It contains the antibiotic gentamicin and is produced by mammalian cells in a nutrient medium using suspension culture. It can be administered intravenously and it appears as a clear colorless sterile, preservative free liquid concentration available as 100mg/10ml or 500mg/50ml vials. The pH of Rituximab is 7.4 and formulated using sodium citrate dihydrate, sodium chloride, polysorbate 80 and water for injecting purposes [29-31].